Rapid Response of Stem Cells and Immune Cells for Efficacy
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Placebo, Chaga Mushroom, Ginseng extract, Olive extract.
- Who it may be relevant to
- Registry conditions: Stem Cell Surveillance. Basic parameters: 18 years — 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Rapid Response of Stem Cells and Immune Cells for Efficacy: An Acute Randomized Double-blind Placebo-controlled Cross-over Trial
Overview
The goal for this clinical trial is to compare rapid effects of four products on stem cells, immune activation, and mitochondrial function. A double-blind, placebo-controlled, cross-over study design will be used.
Detailed description
This clinical trial aims at documenting acute effects of consuming four products through evaluation of stem cell surveillance and mitochondrial resilience.
Data on stem cell trafficking will be collected. The testing will show whether consuming the products leads to a rapid change in stem cell surveillance. Data on cellular energy production and mitochondrial resilience in white blood cells under oxidative and inflammatory stress ex vivo will be collected. This testing will show whether consuming the test products leads to support of energy production within mitochondria, under normal and stressed conditions.
Interventions
- Dietary supplement Placebo
2 capsules - Dietary supplement Chaga Mushroom
2 capsules - Dietary supplement Ginseng extract
2 capsules - Dietary supplement Olive extract
2 capsules - Dietary supplement Potassium Hydrogen Glucarate
2 capsules
Primary outcome measures
- Stem cell trafficking [Time frame: Baseline. 1 hour, 2 hours, and 3 hours after ingestion of study drug]
Secondary outcome measures (2)
- Mitochondrial volume per cell [Time frame: Baseline. 1 hour, 2 hours, 3 and hours after ingestion of study drug]
- Mitochondrial membrane potential per cell [Time frame: Baseline. 1 hour, 2 hours, and 3 hours after ingestion of study drug]
Eligibility criteria
Inclusion criteria
- Healthy adults;
- Age 18 - 75 years (inclusive);
- BMI between 18.0 and 34.9 (inclusive);
- Veins easy to see in one or both arms (to allow for the multiple blood draws);
- Willing to comply with study procedures, including:
- Maintaining a consistent diet and lifestyle routine throughout the study,
- Consistent habit of bland breakfasts on days of clinic visits,
- Abstaining from exercising and nutritional supplements on the morning of a study visit,
- Abstaining from use of coffee, tea, and soft drinks for at least one hour prior to a clinic visit;
- Abstaining from music, candy, gum, computer/cell phone use (airplane mode is allowed), during clinic visits.
Exclusion criteria
- Previous major gastrointestinal surgery (absorption of test product may be altered) (minor surgery not a problem, including previous removal of appendix and gall bladder);
- Taking anti-inflammatory medications on a daily basis;
- Currently experiencing intense stressful events/ life changes;
- Currently in intensive athletic training (such as marathon runners);
- Currently taking antipsychotic medications such as clozapine, Risperdal, Abilify, Zyprexa or Seroquel;
- An unusual sleep routine (examples: working graveyard shift, irregular routine with frequent late nights, studying, partying);
- Unwilling to maintain a constant intake of supplements over the duration of the study;
- Anxiety about having blood drawn;
- Pregnant, nursing, or trying to become pregnant;
- Known food allergies related to ingredients in active test product or placebo.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double blind
- Primary purpose
- Prevention
Study locations
United States · 1 center
- NIS Labs — Klamath Falls
Identifiers
NCT: NCT07127705 · 186-006